Bioactive Materials Associate Editor Ke Cheng Elected Foreign Member of Academia Europaea

Published 17 November, 2026

Columbia University biomedical engineer recognized for his work in nanobiotechnology and regenerative medicine

Professor Ke Cheng, Associate Editor of Bioactive Materials (BAM) and Alan L. Kaganov Professor of Biomedical Engineering at Columbia University, has been elected a Foreign Member of Academia Europaea, the Academy of Europe. The election was announced by Columbia's Department of Biomedical Engineering, which noted that the honor recognizes his contributions to nanobiotechnology and regenerative medicine.

According to his member record on the Academy's website, Professor Cheng was elected in 2026 to the Basic and Clinical Translational Sciences section, with an additional affiliation to the Cell and Developmental Biology section.

Professor Ke Cheng, newly elected Foreign Member of Academia Europaea. Image: Columbia University Biomedical Engineering

About Academia Europaea

Academia Europaea was founded in 1988 as a non-governmental, pan-European academy. Its members work across the humanities, law, economics and the social sciences, mathematics, medicine, and the natural and technological sciences. The Academy currently has more than 5,500 members, including 88 Nobel laureates, several of whom were elected before receiving the prize.

Membership is by invitation only. Candidates are nominated by existing members and go through peer review of their scholarship before the election is confirmed by the Academy's Board. Most members are based in Europe; scholars working elsewhere join as Foreign Members, and only a small number are admitted each year. The Academy of Sciences of Hong Kong has noted that the acceptance rate for Foreign Members is below 5%.

About Professor Ke Cheng

Professor Ke Cheng, Columbia University

Ke Cheng received his B.S. in chemical engineering from Zhejiang University and his Ph.D. in bioengineering from the University of Georgia. Before joining Columbia in July 2023, he was the Randall B. Terry, Jr. Distinguished Professor at North Carolina State University. At Columbia he also holds an appointment in the Department of Medicine (Cardiology) and is a member of the Herbert Irving Comprehensive Cancer Center. From 2022 to 2024 he chaired the NIH Biomaterials and Biointerfaces (BMBI) study section.

His laboratory works on adult stem cells, extracellular vesicles, biomaterials and nanomedicine, with a focus on cardiac and pulmonary repair and regeneration. The group combines magnetic and molecular targeting, hydrogels, nanomaterials and imaging to develop new biotherapeutics. Its work has appeared in Nature Materials, Nature Nanotechnology, Nature Biomedical Engineering, Science Translational Medicine, Circulation Research and the European Heart Journal, and several of its programs have obtained Investigational New Drug (IND) clearance from the U.S. FDA.

Professor Cheng is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), the Biomedical Engineering Society (BMES), the International Academy of Medical and Biological Engineering (IAMBE) and the American Heart Association (AHA). He received the BMES Wallace H. Coulter Award for Healthcare Innovation in 2024 and has been named a Clarivate Highly Cited Researcher every year from 2022 to 2025. He serves as Editor-in-Chief of Extracellular Vesicle (Elsevier) and Associate Editor of Bioactive Materials (KeAi).

The editorial office of Bioactive Materials congratulates Professor Cheng on his election.

About Bioactive Materials

Bioactive Materials was launched in 2016 and has been indexed in SCIE since 2019. Its latest Journal Impact Factor, released in June 2026, is 23.6, placing it 2nd of 58 journals in Materials Science, Biomaterials and 3rd of 130 in Engineering, Biomedical. From 2020 to 2025 the journal was ranked in Zone 1 (Top) of the Chinese Academy of Sciences journal ranking, and it is listed in the T1 tier of China’s high-quality sci-tech journal catalogue for materials science.


Media contact: Bioactive Materials Editorial Office, jessica.wang@keaipublishing.com

Sources: Columbia University Department of Biomedical Engineering; Academia Europaea (ae-info.org); KeAi Publishing.

Back to News from Bioactive Materials

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.